ANI Pharmaceuticals
ANIP
#5249
Rank
HK$9.14 B
Marketcap
HK$435.15
Share price
1.47%
Change (1 day)
8.86%
Change (1 year)

Operating Margin for ANI Pharmaceuticals (ANIP)

Operating Margin as of November 2024 (TTM): 6.58%

According to ANI Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 6.58%. At the end of 2023 the company had an Operating Margin of 4.08%.

Operating Margin history for ANI Pharmaceuticals from 2001 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
20234.08%-120.61%
2022-19.81%-23.63%
2021-25.94%108.27%
2020-12.45%-914.76%
20191.53%-84.63%
20189.95%7.59%
20179.24%37.03%
20166.75%-76.31%
201528.48%-17.76%
201434.62%8166.32%
20130.42%-100.03%
2012-1,210.03%-89.8%
2011-11,859.66%535.2%
2010-1,867.09%-38.87%
2009-3,054.36%541.07%
2008-476.45%-72.93%
2007-1,760.34%-7489.15%
200623.82%-100.66%
2005-3,600.61%-77.14%
2004-15,749.47%70.61%
2003-9,231.29%6764.93%
2002-134.47%-15.65%
2001-159.43%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
7.60% 15.50%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-80.08%-1,317.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-3.93%-159.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
1.80%-72.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-43.36%-758.97%๐Ÿ‡บ๐Ÿ‡ธ USA
-2,054.75%-31,327.20%๐Ÿ‡บ๐Ÿ‡ธ USA
0.31%-95.29%๐Ÿ‡บ๐Ÿ‡ธ USA
25.49% 287.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
54.35% 725.99%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.